查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1985079

2026年煙醯胺腺嘌呤二核苷酸全球市場報告

Nicotinamide Adenine Dinucleotide Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，菸鹼醯胺腺嘌呤二核苷酸 (NAD) 的市場規模迅速擴張。預計該市場規模將從 2025 年的 55.9 億美元成長到 2026 年的 64.8 億美元，複合年成長率 (CAGR) 為 16.1%。過去幾年成長要素包括：抗衰老補充劑需求增加、細胞代謝研究的進展、預防醫學意識的提高、營養保健品（機能性食品）銷售管道的拓展，以及健康和生物駭客產品的日益普及。

預計未來幾年煙醯胺腺嘌呤二核苷酸 (NAD) 市場將快速成長，到 2030 年將達到 116.5 億美元，複合年成長率 (CAGR) 為 15.8%。預測期內的成長要素包括：消費者對延年益壽和活力解決方案的支出增加、主流膳食補充劑中 NAD 前體成分的採用率提高、靜脈輸液療法和再生醫學診所的擴張、製藥公司對 NAD 在慢性病管理中應用的興趣日益濃厚，以及在線個性化補充劑項目的日益普及。預測期內的關鍵趨勢包括：緩釋和脂質體遞送形式的技術進步、多成分延年益壽配方的創新、基於 NAD 的皮膚病和護膚活性成分的開發、用於治療神經系統和代謝性疾病的治療級 NAD 的研發，以及基於生物標記的個性化補充劑平台的進步。

預計未來幾年，與老齡化相關的代謝性疾病的日益普遍將推動煙醯胺腺嘌呤二核苷酸 (NAD+)老齡化的成長。這些疾病包括糖尿病、肥胖症、心血管疾病和神經退化性疾病，它們都與老齡化、代謝失調和細胞功能障礙有關。人口老化以及久坐不動、熱量攝取過量和肥胖率上升等不健康生活方式的盛行，導致這些疾病的盛行率不斷上升。 NAD+ 在細胞能量代謝、粒線體功能和 DNA 修復過程中發揮關鍵作用，有助於控制這些疾病，而這些過程對於維持代謝健康和延緩與老齡化相關的細胞功能衰退至關重要。例如，總部位於比利時的非營利組織國際糖尿病聯盟（IDF）於2025年2月預測，到2030年，65歲以上糖尿病患者人數將達到1.952億（成長19.6%），到2045年將達到2.762億。該聯盟代表全球糖尿病協會。這凸顯了老化社會中糖尿病負擔的顯著增加，這將對公共衛生和經濟產生重大影響。因此，與老齡化相關的疾病和代謝紊亂盛行率的上升正在推動NAD+市場的成長。

煙醯胺腺嘌呤二核苷酸 (NAD+) 市場的主要企業正致力於開發先進配方，例如 NAD+護膚補充劑，以支持抗衰老並改善皮膚健康。 NAD+護膚補充劑是口服或外用產品，旨在透過提高皮膚細胞中的 NAD+ 水平，促進細胞能量、修復和抗衰老過程，從而改善皮膚健康和外觀。例如，2025 年 11 月，總部位於美國的 NAD+ 生物科技公司 ChromaDex Corporation 推出了 Tru Niagen Beauty，這是美國首款 NAD+護膚補充劑。本產品採用經臨床研究的精準配方成分，包括取得專利的菸鹼醯胺核苷 (Niagen)。它旨在透過提高 NAD+ 的可用性來支持細胞能量產生、皮膚健康和整體健康，而 NAD+ 的含量會隨著老齡化的成長而自然下降。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球煙醯胺腺嘌呤二核苷酸市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 永續性、氣候技術、循環經濟
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
  • 主要趨勢
    • 對含NAD+的延年益壽補充劑的需求日益成長
    • 擴大NAD+在臨床靜脈治療的應用
    • 擴大 NAD+ 前驅物在保健產品的應用
    • 拓展抗衰老和代謝健康配方
    • 人們越來越重視最佳化細胞能量

第5章 終端用戶產業市場分析

  • 一般消費者
  • 醫療保健提供者
  • 製藥公司
  • 健康診所
  • 研究和生物技術組織

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球煙醯胺腺嘌呤二核苷酸市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球煙醯胺腺嘌呤二核苷酸市場規模、比較及成長率分析
  • 全球菸鹼醯胺腺嘌呤二核苷酸市場表現：規模與成長，2020-2025年
  • 全球菸鹼醯胺腺嘌呤二核苷酸市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 口服煙醯胺腺嘌呤二核苷酸補充劑、煙醯胺腺嘌呤二核苷酸和 NADH 直接組合膠囊、煙醯胺腺嘌呤二核苷酸注射劑和輸液產品、專門的抗衰老和代謝製劑、煙醯胺腺嘌呤二核苷酸前體、用於局部和美容用途的煙醯胺腺嘌呤二核苷酸製劑。
  • 按年級
  • 食品級、醫藥級及其他等級
  • 透過分銷管道
  • 線上與電子商務、線下管道
  • 透過使用
  • 營養補充品和保健品、藥品和治療劑、化妝品和皮膚病學、臨床靜脈輸液療法和再生醫學、研究和生物技術
  • 最終用戶
  • 一般消費者、醫療保健專業人員、製藥公司
  • 按類型細分：口服煙醯胺腺嘌呤二核苷酸補充劑
  • 能量補充片、促進健康老齡化的膠囊、代謝支持粉、免疫健康片、認知功能支持膠囊
  • 按類型細分：煙醯胺腺嘌呤二核苷酸和 NADH 直接組合膠囊
  • 煙醯胺腺嘌呤二核苷酸膠囊、還原型煙醯胺腺嘌呤二核苷酸膠囊、細胞能量增強膠囊、粒線體支撐膠囊、高效能煙醯胺腺嘌呤二核苷酸膠囊
  • 按類型細分：煙醯胺腺嘌呤二核苷酸（NAD+）注射劑和靜脈注射劑
  • 靜脈注射煙醯胺腺嘌呤二核苷酸溶液、肌肉注射煙醯胺腺嘌呤二核苷酸、高濃度煙醯胺腺嘌呤二核苷酸輸液、排毒支持輸液、再生健康輸液混合物
  • 按類型細分：專業抗衰老和代謝配方
  • 細胞再生配方、粒線體活化配方、延年益壽配方、新陳代謝促進配方、排毒支持配方
  • 按類型細分：煙醯胺腺嘌呤二核苷酸的前體
  • 煙醯胺單核苷酸片、煙醯胺核苷膠囊、煙醯胺片、煙醯胺腺嘌呤二核苷酸路徑支持粉末、促進健康老齡化的前驅混合物
  • 按類型細分：用於局部和化妝品用途的煙醯胺腺嘌呤二核苷酸製劑
  • 抗老臉部精華液、肌膚修補保濕霜、美白臉霜、屏障功能強化乳液、眼部煥膚凝膠

第10章 區域與國別分析

  • 全球菸鹼醯胺腺嘌呤二核苷酸市場：依地區分類，歷史資料及預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球菸鹼醯胺腺嘌呤二核苷酸市場：依國家分類，歷史資料及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 煙鹼醯胺腺嘌呤二核苷酸市場：競爭格局及市場佔有率，2024年
  • 煙醯胺腺嘌呤二核苷酸市場：公司估值矩陣
  • 煙醯胺腺嘌呤二核苷酸市場：公司概況
    • Thermo Fisher Scientific Inc.
    • Life Extension Foundation Buyers Club Inc.
    • Niagen Bioscience Inc.
    • Tokyo Chemical Industry Co. Ltd.
    • Otto Chemie Pvt. Ltd.

第37章 其他大型企業和創新企業

  • HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi'an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen（Shanghai）Biotechnology Co. Ltd.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

  • 2030年煙醯胺腺嘌呤二核苷酸市場：提供新機會的國家
  • 2030年菸鹼醯胺腺嘌呤二核苷酸市場：充滿新機會的細分市場
  • 煙鹼醯胺腺嘌呤二核苷酸市場2030：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH6MNADD01_G26Q1

Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme present in all living cells that plays a crucial role in cellular metabolism. It primarily acts as an electron carrier in redox reactions, facilitating the conversion of nutrients into energy by transferring electrons in processes such as glycolysis, the citric acid cycle, and oxidative phosphorylation. Additionally, NAD+ is involved in DNA repair, regulation of gene expression, and cell signaling.

The primary product types of nicotinamide adenine dinucleotide (NAD) include oral nicotinamide adenine dinucleotide supplements, nicotinamide adenine dinucleotide and NADH direct-ingredient capsules, nicotinamide adenine dinucleotide injection and infusion products, specialized anti-aging and metabolic formulations, nicotinamide adenine dinucleotide precursors, and topical and cosmetic nicotinamide adenine dinucleotide formulations. Oral nicotinamide adenine dinucleotide supplements refer to orally administered products that deliver nicotinamide adenine dinucleotide or its precursors to support cellular energy metabolism, healthy aging, and overall wellness. The various grades include food grade, pharmaceutical grade, and others. The distribution channels include online and e-commerce and offline channels. The applications include dietary supplements and wellness, pharmaceuticals and therapeutics, cosmetics and dermatology, clinical IV therapy, regenerative medicine, and research and biotechnology, and the key end users include individual consumers, healthcare providers, and pharmaceutical companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the nicotinamide adenine dinucleotide market by increasing costs of imported pharmaceutical-grade raw materials, biochemical intermediates, encapsulation inputs, and sterile processing equipment used in supplement and infusion product manufacturing. north america and europe are most affected due to dependence on imported active ingredients and specialized processing technologies, while asia-pacific faces cost pressure on export-oriented production. these tariffs are raising product prices and compliance costs across dietary supplement, pharmaceutical, and cosmetic segments. however, they are also encouraging localized production, regional sourcing of precursors, and increased investment in domestic biomanufacturing capabilities.

The nicotinamide adenine dinucleotide market research report is one of a series of new reports from The Business Research Company that provides nicotinamide adenine dinucleotide market statistics, including nicotinamide adenine dinucleotide industry global market size, regional shares, competitors with a nicotinamide adenine dinucleotide market share, detailed nicotinamide adenine dinucleotide market segments, market trends and opportunities, and any further data you may need to thrive in the nicotinamide adenine dinucleotide industry. This nicotinamide adenine dinucleotide market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nicotinamide adenine dinucleotide market size has grown rapidly in recent years. It will grow from $5.59 billion in 2025 to $6.48 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing demand for anti-aging supplements, growing research on cellular metabolism, rising awareness of preventive healthcare, expansion of nutraceutical distribution channels, increasing adoption of wellness and biohacking products.

The nicotinamide adenine dinucleotide market size is expected to see rapid growth in the next few years. It will grow to $11.65 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to growing consumer spending on longevity and vitality solutions, increasing adoption of nad precursors in mainstream supplements, rising expansion of IV therapy and regenerative clinics, increasing pharmaceutical interest in nad for chronic disease management, expanding penetration of online personalized supplement programs. Major trends in the forecast period include technology advancements in sustained-release and liposomal delivery formats, innovations in multi-ingredient longevity formulations, developments in nad-based dermatology and skincare actives, research and developments in therapeutic-grade nad for neurological and metabolic disorders, advancements in biomarker-based personalized supplementation platforms.

The increasing prevalence of age-related and metabolic disorders is expected to drive the growth of the nicotinamide adenine dinucleotide (NAD+) market in the coming years. Age-related and metabolic disorders include conditions such as diabetes, obesity, cardiovascular diseases, and neurodegenerative disorders, which are linked to aging, impaired metabolism, and cellular dysfunction. Their prevalence is rising due to aging populations and the widespread adoption of unhealthy lifestyle patterns, including sedentary behavior, excessive calorie intake, and increasing obesity rates. NAD+ supports the management of these disorders by playing a key role in cellular energy metabolism, mitochondrial function, and DNA repair processes, which are essential for maintaining metabolic health and mitigating age-associated cellular decline. For example, in February 2025, the International Diabetes Federation, a Belgium-based nonprofit representing diabetes associations worldwide, projected that the number of people over 65 years with diabetes would reach 195.2 million (19.6%) by 2030 and 276.2 million by 2045, highlighting a significant increase in diabetes burden in aging populations with major public health and economic implications. Consequently, the rising prevalence of age-related and metabolic disorders is fueling the growth of the NAD+ market.

Leading companies in the nicotinamide adenine dinucleotide (NAD+) market are focusing on developing advanced formulations, such as NAD+ skincare supplements, to support anti-aging and enhance skin health. NAD+ skincare supplements are dietary or topical products designed to boost NAD+ levels in skin cells, promoting cellular energy, repair, and anti-aging processes to improve skin health and appearance. For example, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen Beauty, the first NAD+ skincare supplement available in the United States. The product features a precision blend of clinically studied ingredients, including its patented nicotinamide riboside (Niagen), aimed at supporting cellular energy production, skin health, and overall wellness by increasing NAD+ availability, which naturally declines with age.

In October 2023, L Catterton Management Company LLC, a US-based consumer-focused investment firm, acquired Thorne HealthTech Inc. for an undisclosed sum. This acquisition allowed L Catterton to expand its presence in the personalized wellness and longevity-focused nutrition markets by leveraging Thorne's established product portfolio, research and development capabilities, and direct-to-consumer reach. Thorne HealthTech Inc. is a US-based nutritional supplement company specializing in nicotinamide adenine dinucleotide (NAD)-related health products.

Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi'an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nicotinamide adenine dinucleotide market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nicotinamide adenine dinucleotide market consists of sales of NAD+ supplements, NADH formulations, nicotinamide riboside (NR) products, nicotinamide mononucleotide (NMN) products, and related nutraceuticals and functional foods. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nicotinamide Adenine Dinucleotide Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nicotinamide adenine dinucleotide market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nicotinamide adenine dinucleotide ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nicotinamide adenine dinucleotide market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements; Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules; Nicotinamide Adenine Dinucleotide Injection and Infusion Products; Specialized Anti-Aging and Metabolic Formulations; Nicotinamide Adenine Dinucleotide Precursors; Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations
  • 2) By Grade: Food Grade; Pharmaceutical Grade; Other Grades
  • 3) By Distribution Channel: Online and E-commerce; Offline Channels
  • 4) By Application: Dietary Supplements and Wellness; Pharmaceuticals and Therapeutics; Cosmetics and Dermatology; Clinical IV Therapy and Regenerative Medicine; Research and Biotechnology
  • 5) By End User: Individual Consumers; Healthcare Providers; Pharmaceutical Companies
  • Subsegments:
  • 1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets; Healthy Aging Capsules; Metabolism Support Powder; Immune Wellness Tablet; Cognitive Support Capsules
  • 2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules; Nicotinamide Adenine Dinucleotide Reduced Capsules; Cellular Energy Enhancement Capsules; Mitochondrial Support Capsules; High Potency Nicotinamide Adenine Dinucleotide Capsules
  • 3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions; Intramuscular Nicotinamide Adenine Dinucleotide Shots; High Concentration Nicotinamide Adenine Dinucleotide Infusions; Detoxification Support Infusions; Regenerative Wellness Infusion Blends
  • 4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas; Mitochondrial Activation Formulas; Longevity Support Formulas; Metabolic Enhancement Formulas; Detoxification Support Formulas
  • 5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets; Nicotinamide Riboside Capsules; Nicotinamide Tablets; Nicotinamide Adenine Dinucleotide Pathway Support Powders; Healthy Aging Precursor Blends
  • 5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums; Skin Repair Moisturizers; Brightening Facial Creams; Barrier Strengthening Lotions; Eye Area Rejuvenation Gels
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Life Extension Foundation Buyers Club Inc.; Niagen Bioscience Inc.; Tokyo Chemical Industry Co. Ltd.; Otto Chemie Pvt. Ltd.; HiMedia Laboratories Pvt. Ltd.; Sichuan Benepure Pharmaceutical; F. Hoffmann-La Roche Ltd; Herbalmax Ltd.; Nuray Chemicals Private Limited; Hefei Home Sunshine Pharmaceutical Technology Co. Ltd.; Syncozymes Biotechnology Co. Ltd.; OYC Americas Inc.; Xi'an Yinherb Bio-Tech Co. Ltd.; Shenzhen Hygieia Biotechnology Co. Ltd.; Zhejiang Dazhan Biotechnology Co. Ltd.; Willow Birch Pharma Inc.; Hubei AOKS Bio-Tech Co. Ltd.; Shanghai Neutan Pharmaceutical Co. Ltd.; Evereen (Shanghai) Biotechnology Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Nicotinamide Adenine Dinucleotide Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Nicotinamide Adenine Dinucleotide Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Nicotinamide Adenine Dinucleotide Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Nicotinamide Adenine Dinucleotide Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Sustainability, Climate Tech & Circular Economy
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Demand For Nad+ Based Longevity Supplements
    • 4.2.2 Rising Use Of Nad+ In Clinical Iv Therapy
    • 4.2.3 Growing Adoption Of Nad+ Precursors In Wellness Products
    • 4.2.4 Expansion Of Anti-Aging And Metabolic Health Formulations
    • 4.2.5 Enhanced Focus On Cellular Energy Optimization

5. Nicotinamide Adenine Dinucleotide Market Analysis Of End Use Industries

  • 5.1 Individual Consumers
  • 5.2 Healthcare Providers
  • 5.3 Pharmaceutical Companies
  • 5.4 Wellness Clinics
  • 5.5 Research And Biotechnology Organizations

6. Nicotinamide Adenine Dinucleotide Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nicotinamide Adenine Dinucleotide Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Nicotinamide Adenine Dinucleotide PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Nicotinamide Adenine Dinucleotide Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Nicotinamide Adenine Dinucleotide Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Nicotinamide Adenine Dinucleotide Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nicotinamide Adenine Dinucleotide Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nicotinamide Adenine Dinucleotide Market Segmentation

  • 9.1. Global Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations
  • 9.2. Global Nicotinamide Adenine Dinucleotide Market, Segmentation By Grade, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Food Grade, Pharmaceutical Grade, Other Grades
  • 9.3. Global Nicotinamide Adenine Dinucleotide Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Online and E-commerce, Offline Channels
  • 9.4. Global Nicotinamide Adenine Dinucleotide Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology
  • 9.5. Global Nicotinamide Adenine Dinucleotide Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Individual Consumers, Healthcare Providers, Pharmaceutical Companies
  • 9.6. Global Nicotinamide Adenine Dinucleotide Market, Sub-Segmentation Of Oral Nicotinamide Adenine Dinucleotide Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules
  • 9.7. Global Nicotinamide Adenine Dinucleotide Market, Sub-Segmentation Of Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules
  • 9.8. Global Nicotinamide Adenine Dinucleotide Market, Sub-Segmentation Of Nicotinamide Adenine Dinucleotide Injection and Infusion Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends
  • 9.9. Global Nicotinamide Adenine Dinucleotide Market, Sub-Segmentation Of Specialized Anti-Aging and Metabolic Formulations, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas
  • 9.10. Global Nicotinamide Adenine Dinucleotide Market, Sub-Segmentation Of Nicotinamide Adenine Dinucleotide Precursors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends
  • 9.11. Global Nicotinamide Adenine Dinucleotide Market, Sub-Segmentation Of Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels

10. Nicotinamide Adenine Dinucleotide Market Regional And Country Analysis

  • 10.1. Global Nicotinamide Adenine Dinucleotide Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Nicotinamide Adenine Dinucleotide Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nicotinamide Adenine Dinucleotide Market

  • 11.1. Asia-Pacific Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nicotinamide Adenine Dinucleotide Market

  • 12.1. China Nicotinamide Adenine Dinucleotide Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nicotinamide Adenine Dinucleotide Market

  • 13.1. India Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nicotinamide Adenine Dinucleotide Market

  • 14.1. Japan Nicotinamide Adenine Dinucleotide Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nicotinamide Adenine Dinucleotide Market

  • 15.1. Australia Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nicotinamide Adenine Dinucleotide Market

  • 16.1. Indonesia Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nicotinamide Adenine Dinucleotide Market

  • 17.1. South Korea Nicotinamide Adenine Dinucleotide Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nicotinamide Adenine Dinucleotide Market

  • 18.1. Taiwan Nicotinamide Adenine Dinucleotide Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nicotinamide Adenine Dinucleotide Market

  • 19.1. South East Asia Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nicotinamide Adenine Dinucleotide Market

  • 20.1. Western Europe Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nicotinamide Adenine Dinucleotide Market

  • 21.1. UK Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nicotinamide Adenine Dinucleotide Market

  • 22.1. Germany Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nicotinamide Adenine Dinucleotide Market

  • 23.1. France Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nicotinamide Adenine Dinucleotide Market

  • 24.1. Italy Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nicotinamide Adenine Dinucleotide Market

  • 25.1. Spain Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nicotinamide Adenine Dinucleotide Market

  • 26.1. Eastern Europe Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nicotinamide Adenine Dinucleotide Market

  • 27.1. Russia Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nicotinamide Adenine Dinucleotide Market

  • 28.1. North America Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nicotinamide Adenine Dinucleotide Market

  • 29.1. USA Nicotinamide Adenine Dinucleotide Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nicotinamide Adenine Dinucleotide Market

  • 30.1. Canada Nicotinamide Adenine Dinucleotide Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nicotinamide Adenine Dinucleotide Market

  • 31.1. South America Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nicotinamide Adenine Dinucleotide Market

  • 32.1. Brazil Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nicotinamide Adenine Dinucleotide Market

  • 33.1. Middle East Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nicotinamide Adenine Dinucleotide Market

  • 34.1. Africa Nicotinamide Adenine Dinucleotide Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Nicotinamide Adenine Dinucleotide Market, Segmentation By Product Type, Segmentation By Grade, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nicotinamide Adenine Dinucleotide Market Regulatory and Investment Landscape

36. Nicotinamide Adenine Dinucleotide Market Competitive Landscape And Company Profiles

  • 36.1. Nicotinamide Adenine Dinucleotide Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Nicotinamide Adenine Dinucleotide Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Nicotinamide Adenine Dinucleotide Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Life Extension Foundation Buyers Club Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Niagen Bioscience Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Tokyo Chemical Industry Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Otto Chemie Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Nicotinamide Adenine Dinucleotide Market Other Major And Innovative Companies

  • HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi'an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.

38. Global Nicotinamide Adenine Dinucleotide Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nicotinamide Adenine Dinucleotide Market

40. Nicotinamide Adenine Dinucleotide Market High Potential Countries, Segments and Strategies

  • 40.1 Nicotinamide Adenine Dinucleotide Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Nicotinamide Adenine Dinucleotide Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Nicotinamide Adenine Dinucleotide Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer